The effects of p-chloromercuriphenylsulfonic acid (PCMBS) on force of contraction of mammalian myocardium and on ATP hydrolysis by sarcolemmal ATPase.
D002731:4-Chloromercuribenzenesulfonate / Q000494:pharmacology*; D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D004558:Electric Stimulation; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D008627:Mercuric Chloride; D008628:Mercury / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000502:physiology; D010663:Phenylmercury Compounds / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology; D012508:Sarcolemma / Q000378:metabolism*; D012964:Sodium / Q000494:pharmacology
D010663:Phenylmercury Compounds; D008627:Mercuric Chloride; D002731:4-Chloromercuribenzenesulfonate; D000255:Adenosine Triphosphate; D012964:Sodium; D000251:Adenosine Triphosphatases; D008628:Mercury; D011188:Potassium; D009638:Norepinephrine